Autoimmune gastritis has no cure that switches off the immune attack on your stomach lining, so treatment centers on replacing what your body can no longer absorb on its own. That means vitamin B12 and iron first, but the full picture extends well beyond those two supplements. Because the disease quietly destroys the acid-producing cells of the stomach, it disrupts the absorption of several nutrients at once, raises the long-term risk of specific stomach growths, and often travels alongside other autoimmune conditions that need their own management.
What the Disease Actually Does to Your Stomach
Autoimmune gastritis targets the parietal cells in the body and fundus of the stomach. These cells have two critical jobs: they secrete hydrochloric acid and they produce intrinsic factor, the protein you need to absorb vitamin B12 from food. The immune system mistakes a pump enzyme on those cells (the H+/K+-ATPase, sometimes called the proton pump) for a threat and sends T cells and antibodies to destroy them.1PubMed Central. Autoimmune gastritis As the parietal cells die off, two things happen simultaneously: intrinsic factor drops, eventually causing B12 deficiency, and stomach acid disappears, which impairs absorption of inorganic iron and other nutrients.2PubMed Central. Improving the Diagnosis of Autoimmune Gastritis: From Parietal Cell Antibodies to H+/K+ ATPase Antibodies
This dual deficiency is the reason you hear “B12 and iron” so often when autoimmune gastritis comes up. But framing it as just a nutrient problem undersells the condition. The loss of acid reshapes the entire gastric environment, changing which bacteria can survive in the stomach, promoting overgrowth of certain cell types, and raising the risk of both neuroendocrine tumors and, over years, gastric adenocarcinoma.3PubMed Central. Autoimmune gastritis diverges from a shared corpus origin: molecular reconstruction of the adenocarcinoma axis and clinical anchoring of the neuroendocrine axis Good treatment means addressing all of these consequences, not just the anemia.
Vitamin B12 Replacement
For decades, the standard teaching was that people with pernicious anemia (the end-stage B12 deficiency caused by autoimmune gastritis) had to get B12 by injection because they lacked intrinsic factor. That logic sounds airtight until you learn that a small percentage of B12 is absorbed through passive diffusion across the gut wall, bypassing intrinsic factor entirely. When the oral dose is high enough, that passive route can deliver plenty.
A Cochrane review comparing oral and intramuscular B12 found that high oral doses (1,000 to 2,000 micrograms per day) brought blood levels up just as well as injections, with one trial using 2,000 micrograms per day actually showing higher final B12 levels in the oral group.4PubMed Central. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency An earlier version of the same Cochrane review also confirmed similar improvements in blood counts and neurological symptoms between the two routes.5PubMed Central. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency A more recent prospective study specifically focused on pernicious anemia patients found that oral supplementation was effective at correcting deficiency markers both short-term and long-term, and argued that the oral route should generally be preferred because it is cheaper, patients like it better, and it avoids the bleeding risk that injections pose for people on blood thinners.6The American Journal of Clinical Nutrition. Oral vitamin B12 supplementation in pernicious anemia: a prospective cohort study
In practice, many doctors still start with a loading course of injections (often weekly for a month, then monthly) because it guarantees absorption in someone who may be severely depleted. Switching to high-dose oral supplements for maintenance is increasingly common and well supported. The key is that the oral dose needs to be pharmacological, not the 2.4 micrograms you would get from a standard multivitamin. Your doctor will typically prescribe 1,000 to 2,000 micrograms daily.
How Quickly B12 Symptoms Improve
Blood counts tend to bounce back within weeks of starting treatment, but neurological symptoms follow a slower, less predictable schedule. A Delphi expert consensus on B12 deficiency management noted that tingling and balance problems are often the first symptoms to improve, and subjective improvement usually outpaces what can be measured on a neurological exam. Full recovery of sensory symptoms can take up to a year. Roughly one in four patients retains some degree of neurological impairment even after blood markers return to normal, and about one in five sees recovery that is still incomplete three months into treatment.7PubMed Central. Diagnosis, Treatment and Long-Term Management of Vitamin B12 Deficiency in Adults: A Delphi Expert Consensus
The takeaway is that B12 replacement works, but patience is non-negotiable for neurological recovery. If you were diagnosed late and already have numbness, weakness, or gait problems, complete resolution is not guaranteed. Early detection and treatment give the best chance of full reversal.
Iron Replacement and the Problem With Oral Iron
Iron deficiency in autoimmune gastritis is common and often shows up years before B12 deficiency does, partly because iron stores deplete faster. Without stomach acid, the form of iron found in plant foods and supplements (non-heme iron) is poorly absorbed. Oral iron tablets may barely work for someone whose stomach no longer acidifies its contents.
Intravenous iron bypasses the gut entirely and can deliver a meaningful dose in a single infusion. A retrospective study of patients with iron-deficiency anemia caused by corpus atrophic gastritis found that intravenous ferric carboxymaltose raised hemoglobin by about 3 grams per deciliter and was safe and well tolerated. However, the anemia relapsed in over half the patients at roughly two years on average, and women were significantly more likely to relapse.8PubMed Central. Efficacy and Safety of Intravenous Ferric Carboxymaltose Treatment of Iron Deficiency Anaemia in Patients with Corpus Atrophic Gastritis: A Retrospective Study This means intravenous iron is not a one-time fix. Regular monitoring of ferritin and hemoglobin is essential, and many patients will need periodic re-infusion.
Some clinicians try oral iron with vitamin C (which helps convert iron to its more absorbable form) before escalating to infusion. That approach can work for mild deficiency, but if your anemia is not budging after a few months of oral iron, IV is likely the next step.
Restoring Stomach Acid With Betaine HCl
One emerging treatment idea targets the lost acid itself rather than just patching the nutrient gaps it creates. Betaine hydrochloride is an over-the-counter supplement that temporarily lowers stomach pH when taken with meals. A study in healthy volunteers whose stomach acid was suppressed by a proton-pump inhibitor showed that a dose of betaine HCl dropped gastric pH from around 5.2 to about 0.6 within minutes, though the effect lasted only a little over an hour.9PubMed Central. Gastric reacidification with betaine HCl in healthy volunteers with rabeprazole-induced hypochlorhydria
Proponents argue that mealtime acid supplementation could improve nutrient absorption, ease digestive symptoms like bloating and early fullness, and possibly even reduce the cancer-promoting effects of chronic low acid, such as elevated gastrin levels and formation of harmful nitrogen-containing compounds in the stomach.10PubMed Central. Creating a Framework for Treating Autoimmune Gastritis-The Case for Replacing Lost Acid The evidence is still largely theoretical and based on physiological reasoning rather than clinical trials in autoimmune gastritis patients. Still, the concept makes intuitive sense, and some gastroenterologists are cautiously supportive of trying it. If you explore this route, work with your doctor to establish a safe dose and make sure it does not irritate an already inflamed stomach.
The Helicobacter Pylori Connection
The relationship between H. pylori infection and autoimmune gastritis is one of the more complicated stories in gastroenterology. Research has shown that H. pylori bacteria carry proteins that structurally resemble the proton pump enzyme on parietal cells. In people with the right genetic susceptibility, the immune system’s attack on H. pylori can spill over into an attack on the body’s own parietal cells through a process called molecular mimicry.11PubMed Central. Molecular mimicry between Helicobacter pylori antigens and H+, K+ –adenosine triphosphatase in human gastric autoimmunity12PubMed. Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry In other words, an H. pylori infection can potentially trigger or accelerate autoimmune gastritis in susceptible people.
Eradicating H. pylori in patients who carry both the infection and the autoimmune process produces mixed results. One study found that in 80% of patients with early, non-atrophic autoimmune gastritis, clearing H. pylori led to healing of the active inflammation, with reduced gland destruction and less immune cell infiltration.13PubMed. Healing of active, non-atrophic autoimmune gastritis by H. pylori eradication But a case report documented the opposite: a patient whose autoimmune gastritis progressed rapidly after eradication therapy, with worsening atrophy over the following three years.14PubMed Central. Rapid Progression of Autoimmune Gastritis after Helicobacter pylori Eradication Therapy One theory is that removing the infection unmasks or accelerates the autoimmune process that H. pylori was partially keeping in check through chronic immune distraction.
The practical bottom line: if you have autoimmune gastritis and also test positive for H. pylori, most guidelines recommend eradication because the infection carries its own cancer risk. But your gastroenterologist should follow your atrophy closely afterward, since the autoimmune component may shift gears once the bacteria are gone.
Other Nutrients You Might Be Missing
B12 and iron get the headlines, but a stomach that no longer makes acid struggles to absorb more than just those two. A review of micronutrient deficiencies in chronic autoimmune gastritis patients found increasing reports of low vitamin C, vitamin D, folic acid, and calcium.15PubMed Central. Micronutrient deficiencies in patients with chronic atrophic autoimmune gastritis: A review Vitamin C absorption is pH-dependent, and calcium (particularly the carbonate form, which is the cheapest and most common supplement type) requires acid for dissolution. Vitamin D deficiency compounds the calcium problem because D is essential for calcium absorption further downstream in the intestine.
This means a comprehensive treatment plan should include periodic blood tests for these nutrients, not just B12 and ferritin. Switching to calcium citrate instead of calcium carbonate can help, since citrate does not require acid to dissolve. Vitamin D supplementation is straightforward. And while folic acid is not typically as affected as B12, folate levels are still worth checking, especially in women of childbearing age.
Monitoring for Stomach Growths
Chronic loss of acid triggers a feedback loop: the G cells in the antrum of the stomach keep pumping out gastrin (the hormone that normally tells parietal cells to make more acid) because they never get the signal that acid levels are adequate. This sustained high gastrin stimulates specialized cells called enterochromaffin-like (ECL) cells in the stomach lining to proliferate. Over time, that proliferation can evolve into type 1 gastric neuroendocrine tumors. A study of autoimmune gastritis patients found that ECL-cell overgrowth in the corpus was strongly linked to the development of these tumors.16PubMed Central. Factors associated with type 1 gastric neuroendocrine tumor occurrence in autoimmune atrophic gastritis: insights from a real-world cohort Type 1 neuroendocrine tumors are generally small and slow-growing, and most can be managed endoscopically, but they do need to be caught.
The AGA’s clinical practice update on atrophic gastritis advises that endoscopic surveillance should be considered but acknowledges that the ideal interval is not well-defined. For advanced atrophic gastritis, a surveillance endoscopy roughly every three years is a reasonable starting point, though the decision should be individualized.17PubMed Central. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review British guidelines recommend that people aged 50 or older with laboratory evidence of pernicious anemia should at minimum have a baseline endoscopy with biopsies from both the greater and lesser curves of the corpus.18Gut. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma
Between endoscopies, blood biomarkers can help track disease progression. Gastrin-17 levels, pepsinogen I, pepsinogen II, and the pepsinogen I/II ratio all shift as atrophy worsens. One study found that gastrin and the pepsinogen I/II ratio each had strong diagnostic accuracy for detecting autoimmune gastritis, with areas under the ROC curve above 0.91.19Scientific Reports. Relevance of pepsinogen, gastrin, and endoscopic atrophy in the diagnosis of autoimmune gastritis These blood tests are not perfect substitutes for endoscopy, but they can flag progression between scopes and help your doctor decide when the next one is due.
Associated Autoimmune Conditions
Autoimmune gastritis rarely travels alone. Hashimoto’s thyroiditis is the most frequent companion, with studies reporting that around 40% of autoimmune gastritis patients also have Hashimoto’s, and 10 to 40% of Hashimoto’s patients have gastric involvement.20PubMed Central. Hashimoto’s Thyroiditis and Autoimmune Gastritis Type 1 diabetes, vitiligo, and Addison’s disease are also overrepresented. If you have been diagnosed with autoimmune gastritis, screening for thyroid antibodies makes sense, and vice versa. Hypothyroidism can cause fatigue that mimics anemia, so untangling whether your exhaustion is from low iron, low B12, or an underactive thyroid (or all three) requires proper testing for each.
When Immunosuppressive Therapy Enters the Picture
Standard treatment focuses on replacing what the disease takes away, not on stopping the immune attack itself. That said, some researchers and clinicians have explored immunomodulatory drugs in severe or symptomatic cases. In a mouse model, prednisolone successfully reduced inflammation and promoted regeneration of the gastric lining.21PubMed. Prednisolone promotes remission and gastric mucosal regeneration in experimental autoimmune gastritis In humans, at least one case report described a patient with symptomatic autoimmune gastritis that did not respond to steroids, mercaptopurine, adalimumab, budesonide, or hydroxychloroquine, but did respond to mycophenolate mofetil, with near-complete resolution of inflammation on repeat endoscopy.22PubMed Central. Autoimmune Gastritis Treated With Mycophenolate Mofetil
This is not standard care. Most gastroenterologists reserve immunosuppression for patients who are truly refractory and symptomatic, since the treatment carries its own risks and autoimmune gastritis typically progresses slowly enough that nutrient replacement handles the main consequences. But for the minority of patients who develop severe symptoms that do not respond to supportive measures, this option exists and may expand as more data accumulate.
Diagnostic Delay and Why It Matters for Treatment
One of the biggest obstacles to effective treatment is that autoimmune gastritis is frequently diagnosed late. A study of diagnostic delay found that over three-quarters of patients experienced a delayed diagnosis, with a median delay of nearly a year. The primary clues that ultimately led to diagnosis were a “reverse gradient” pattern of atrophy on endoscopy (where the corpus was more damaged than the antrum, the opposite of what H. pylori typically causes) and repeated failures to eradicate H. pylori.23Journal of Army Medical University. Clinical characteristics and contributors to diagnostic delay in autoimmune gastritis Another study found that women and patients who received a previous incorrect diagnosis (such as unexplained iron-deficiency anemia or functional dyspepsia) tended to wait even longer, with misdiagnosed patients facing a median delay of three years.24PubMed. Determinants of diagnostic delay in autoimmune atrophic gastritis
The delay matters because earlier treatment with B12 and iron gives a better shot at full neurological recovery, and earlier surveillance endoscopy means catching any stomach growths sooner. If you have unexplained iron-deficiency anemia, especially if oral iron is not improving it, or if you have another autoimmune condition and develop GI symptoms or anemia, pushing for gastric antibody testing and a proper endoscopy with corpus biopsies can shave months or years off your diagnostic timeline.
Autoimmune Gastritis in Children and Teenagers
The condition is not just an older adult’s disease. Case reports and small series have identified autoimmune gastritis in patients as young as 12, typically presenting with iron-deficiency anemia rather than B12 deficiency. In two reported pediatric cases, the diagnosis was delayed until endoscopic biopsies showed characteristic destruction of the oxyntic glands, and neither child had a family history of autoimmune disease.25PubMed Central. Autoimmune Gastritis in the Pediatric Age: An Underestimated Condition Report of Two Cases and Review
A larger international multicenter study of 51 pediatric autoimmune gastritis patients found a median age of 13, with girls outnumbering boys by nearly two to one. Interestingly, allergic conditions like atopic dermatitis, rhinitis, and asthma were common comorbidities, and a small subset had concurrent eosinophilic esophagitis or eosinophilic gastritis.26PubMed Central. Pediatric autoimmune gastritis: An international, multicentric study The treatment principles are the same as in adults (replace B12, manage iron, monitor), but awareness is the bottleneck. In a child or teenager with iron-deficiency anemia that does not respond to oral supplements, autoimmune gastritis deserves a spot on the differential diagnosis.
How the Gastric Microbiome Shifts
A healthy stomach is a hostile, acidic environment where few bacteria thrive. When parietal cells are destroyed and acid production collapses, the stomach becomes far more hospitable to a wider range of microbes. Research has confirmed that the composition of the gastric microbiome in autoimmune gastritis patients differs significantly from that of people with normal acid levels.27PubMed Central. Autoimmune Gastritis and Gastric Microbiota Some of the bacteria that colonize the low-acid stomach can produce metabolites that may contribute to further mucosal damage or promote the formation of potentially carcinogenic compounds. Small intestinal bacterial overgrowth (SIBO) is also a recognized complication, since the acid barrier that normally prevents bacteria from passing through to the small intestine is weakened. Symptoms of SIBO, including bloating, gas, and diarrhea, overlap heavily with those of autoimmune gastritis itself, so if digestive symptoms persist despite adequate nutrient replacement, SIBO testing (typically a breath test) is worth pursuing.
Upper GI symptoms in autoimmune gastritis, including nausea, early fullness, bloating, and epigastric discomfort, can significantly affect quality of life and require their own management strategies beyond just supplementing the missing nutrients.28PubMed Central. A Comprehensive Review of Upper Gastrointestinal Symptom Management in Autoimmune Gastritis: Current Insights and Future Directions Prokinetic agents, dietary modifications (smaller and more frequent meals, avoiding foods that worsen symptoms), and the acid-replacement approach with betaine HCl mentioned earlier are among the tools clinicians use. No single strategy works for everyone, and managing these symptoms is often a matter of trial and adjustment.